Lisata Therapeutics, Inc.
- Last sale
- Oct 8, 2026 · +1.69%
- Market cap
- $12.96M
- 10.8M shares
- Filings
- 1,028
Q3 2026−83.0% FY24 yoy
Q3 2026N/M FY24 yoy
Q3 2026N/M FY24 yoy
Q3 2026derivedN/M FY24 yoy
Q3 2026N/M FY24 yoy
Q3 2026−1.6% FY24 yoy
- $12.96M
- —
- 129.6×
- 1.7×
- -167.08%
- —
Twelve months to Sep 30, 2026 · derived
Price
Oct 8, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2025-12-31 | $170,000 | reported | |
| FY 2023 | 2024-12-31 | $1,000,000 | reported | |
| FY 2022 | 2022-12-31 | $0 | reported | |
| FY 2016 | 2016-12-31 | $35,283,868 | reported | |
| FY 2015 | 2015-12-31 | $22,487,566 | reported | |
| FY 2014 | 2014-12-31 | $17,938,790 | reported | |
| FY 2013 | 2013-12-31 | $14,668,455 | reported | |
| FY 2012 | 2012-12-31 | $14,329,889 | reported | |
| FY 2011 | 2011-12-31 | $10,050,086 revised | reported | |
| FY 2010 | 2010-12-31 | $69,821,294 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2014 | $0.00 | — | $0.00 | — | 38.46M sh | +34.6% | — |
| FY2013 | $0.00 | — | $0.00 | — | 28.58M sh | −83.0% | — |
| FY2012 | $327.75K | — | $327.75K | — | 168.41M sh | +47.3% | — |
| FY2011 | $0.00 | — | $0.00 | — | 114.35M sh | +78.1% | — |
| FY2010 | $222.92K | — | $222.92K | — | 64.22M sh | — | — |
Pharmaceutical preparations
Lisata Therapeutics, Inc. is the 239th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
HINDVyome Holdings, Inc$319.7K96.0%3,209.7%$11.1MABVCAbvc Biopharma, Inc.$296.0K41.9%2,671.8%$26.2MGDTCCytoMed Therapeutics Ltd$252.3K395.9%1,227.1%$9.8MRGBPRegen BioPharma Inc$236.6K0.0%538.8%$393.7KCLNNClene Inc.$200.0K41.5%13,086.5%$59.8M
LSTALisata Therapeutics, Inc. (this company)$170.0K83.0%9,756.5%$10.8M
SERSerina Therapeutics, Inc.$130.0K132.1%14,755.4%$37.7MBFRGBullFrog AI Holdings, Inc.$116.7K—5,569.6%$10.4MIBIOiBio, Inc.$100.0K75.0%33,044.0%$53.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR